MedPath

青海制药有限公司

Ownership
-
Established
2000-05-31
Employees
-
Market Cap
-
Website
http://www.qhzhiyao.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

176

NMPA:176

Drug Approvals

Compound Balloonflower and Ephedrine Syrup

Product Name
复方桔梗麻黄碱糖浆
Approval Number
国药准字H63020215
Approval Date
Mar 29, 2024
NMPA

Pentoxyverine Citrate and Ammonium Chloride Syrup

Product Name
喷托维林氯化铵糖浆
Approval Number
国药准字H63020196
Approval Date
Mar 29, 2024
NMPA

Naloxone Hydrochloride Injection

Product Name
盐酸纳洛酮注射液
Approval Number
国药准字H20065692
Approval Date
Apr 7, 2022
NMPA

Naloxone Hydrochloride Injection

Product Name
盐酸纳洛酮注射液
Approval Number
国药准字H20065694
Approval Date
Apr 7, 2022
NMPA

Naloxone Hydrochloride Injection

Product Name
盐酸纳洛酮注射液
Approval Number
国药准字H20065693
Approval Date
Mar 21, 2022
NMPA

Pipemidic Acid Tablets

Product Name
吡哌酸片
Approval Number
国药准字H63020100
Approval Date
Jun 1, 2020
NMPA

Vitamin D2 and Calcium Lactate Tablets

Product Name
维D2乳酸钙片
Approval Number
国药准字H63020212
Approval Date
May 28, 2020
NMPA

Vitamin B12 Injection

Product Name
维生素B12注射液
Approval Number
国药准字H63020018
Approval Date
May 28, 2020
NMPA

Vitamin B6 Tablets

Product Name
维生素B6片
Approval Number
国药准字H63020072
Approval Date
May 28, 2020
NMPA

Ethacridine Lactate Injection

Product Name
乳酸依沙吖啶注射液
Approval Number
国药准字H63020043
Approval Date
May 28, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 18
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.